Article
Accelerated immune red cell destruction in the absence of serologically detectable alloantibodies.
Transfusion - 1 Jan 2000
Davey R J, Gustafson M, Holland P V
Abstract excerpt
Two patients are described in whom clinically significant red blood cell alloantibodies could be demonstrated only by in vivo 51chromium (51Cr) survival studies. The first patient had experienced a severe delayed hemolytic transfusion reaction to four units of crossmatch compatible blood. Serial phenotype studies suggested the presence of a serologically undetectable anti-c (hr') antibody. 51Cr survival of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
